Current strategies in overcoming resistance of cancer cells to apoptosis melanoma as a model. (Q36580838)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16939779%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

review article

1 reference

title

Current strategies in overcoming resistance of cancer cells to apoptosis melanoma as a model (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16939779%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16939779%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Peter Hersey

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16939779%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

L Zhuang

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16939779%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16939779%20AND%20SRC:MED&resulttype=core&format=json

International Review of Cytology

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16939779%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

251

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16939779%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

131-158

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16939779%20AND%20SRC:MED&resulttype=core&format=json

A Phase II trial of aprinocarsen, an antisense oligonucleotide inhibitor of protein kinase C alpha, administered as a 21-day infusion to patients with advanced ovarian carcinoma.

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Role of nuclear factor-kappa B in melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Critical upstream signals of cytochrome C release induced by a novel Bcl-2 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Integrin-mediated adhesion regulates ERK nuclear translocation and phosphorylation of Elk-1

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Targeting death and decoy receptors of the tumour-necrosis factor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Proteolytic activation of protein kinase C-epsilon by caspase-mediated processing and transduction of antiapoptotic signals

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Phase II evaluation of bryostatin-1 in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Spontaneous and drug-induced apoptosis is mediated by conformational changes of Bax and Bak in B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Ranking the role of RANK ligand in apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Cancer cell death by programmed necrosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Ten years of protein kinase B signalling: a hard Akt to follow

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

JNK is associated with Bcl-2 and PP1 in mitochondria: paclitaxel induces its activation and its association with the phosphorylated form of Bcl-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Apoptosis genes and resistance to cancer therapy: what does the experimental and clinical data tell us?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Imidazole carboxamide therapy in advanced malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

PUMA couples the nuclear and cytoplasmic proapoptotic function of p53

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

G1/S cell cycle arrest provides anoikis resistance through Erk-mediated Bim suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

The Bcl2 family: regulators of the cellular life-or-death switch

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

The molecular control of DNA damage-induced cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Mutations of the BRAF gene in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Treatment of melanoma cells with a bcl-2/bcl-xL antisense oligonucleotide induces antiangiogenic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Prospects: histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Heat shock protein 90 indirectly regulates ERK activity by affecting Raf protein metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Involvement of protein kinase C delta (PKCdelta) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. Lack of proteolytic cleavage of PKCdelta

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Essential roles of the Bcl-2 family of proteins in caspase-2-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Variable expression of protein kinase C epsilon in human melanoma cells regulates sensitivity to TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Protein kinase C regulates FADD recruitment and death-inducing signaling complex formation in Fas/CD95-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Malignant transformation of melanocytes to melanoma by constitutive activation of mitogen-activated protein kinase kinase (MAPKK) signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

A matter of life and death

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Protein kinase C modulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by targeting the apical events of death receptor signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Bcl-XL is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

JNK/SAPK activity contributes to TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

How melanoma cells evade trail-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Apoptosis and drug response

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Chemosensitisation of malignant melanoma by BCL2 antisense therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Bcl-2 acts in a proangiogenic signaling pathway through nuclear factor-kappaB and CXC chemokines.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Oblimersen Bcl-2 antisense: facilitating apoptosis in anticancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Extracellular signal-regulated kinases 1/2 are serum-stimulated "Bim(EL) kinases" that bind to the BH3-only protein Bim(EL) causing its phosphorylation and turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Regulatory phosphorylation of Bim: sorting out the ERK from the JNK

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Identification of a DEF-type docking domain for extracellular signal-regulated kinases 1/2 that directs phosphorylation and turnover of the BH3-only protein BimEL.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Protein kinase Cdelta targets mitochondria, alters mitochondrial membrane potential, and induces apoptosis in normal and neoplastic keratinocytes when overexpressed by an adenoviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Induction of autophagy and inhibition of tumorigenesis by beclin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

RACK1 mediates activation of JNK by protein kinase C [corrected].

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Phase I and pharmacodynamic study of the oral MEK inhibitor CI-1040 in patients with advanced malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Growth factor regulation of autophagy and cell survival in the absence of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Mitochondrial translocation of protein kinase C delta in phorbol ester-induced cytochrome c release and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

CCI-779 in metastatic melanoma: a phase II trial of the California Cancer Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Perspective: the chemotherapeutic relevance of apoptosis and a proposed biochemical cascade for chemotherapeutically induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

G1 cell-cycle control and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Inhibition of PKCalpha induces a PKCdelta-dependent apoptotic program in salivary epithelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Phorbol 12-myristate 13-acetate inhibits death receptor-mediated apoptosis in Jurkat cells by disrupting recruitment of Fas-associated polypeptide with death domain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

BRAFE600-associated senescence-like cell cycle arrest of human naevi

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Transcription-independent pro-apoptotic functions of p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Selective activation of the c-Jun N-terminal kinase (JNK) pathway fails to elicit Bax activation or apoptosis unless the phosphoinositide 3'-kinase (PI3K) pathway is inhibited

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

The tumor necrosis factor-related apoptosis-inducing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Protein kinase C: structure, function, and regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Pathways of apoptotic and non-apoptotic death in tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

(-)-Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-X(L)-mediated apoptosis resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Colorectal cancer: mutations in a signalling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Microarray expression profiling in melanoma reveals a BRAF mutation signature.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

PTEN inactivation is rare in melanoma tumours but occurs frequently in melanoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

High frequency of BRAF mutations in nevi

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of human farnesyltransferase, BIM-46228.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Functional and therapeutic significance of Akt deregulation in malignant melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Rapamycin inhibits doxorubicin-induced NF-kappaB/Rel nuclear activity and enhances the apoptosis of melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Activation of protein kinase C inhibits TRAIL-induced caspases activation, mitochondrial events and apoptosis in a human leukemic T cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Stimulation of the mitogen-activated protein kinase pathway antagonizes TRAIL-induced apoptosis downstream of BID cleavage in human breast cancer MCF-7 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Caspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

A protective role of PKCepsilon against TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in glioma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated prot

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Farnesyl transferase inhibitor SCH66336 is cytostatic, pro-apoptotic and enhances chemosensitivity to cisplatin in melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

BRAF mutation predicts sensitivity to MEK inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Initiation of apoptosis by granzyme B requires direct cleavage of bid, but not direct granzyme B-mediated caspase activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Protein kinase C inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

A small molecule compound inhibits AKT pathway in ovarian cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Mcl-1 antisense therapy chemosensitizes human melanoma in a SCID mouse xenotransplantation model

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Mcl-1 is a novel therapeutic target for human sarcoma: synergistic inhibition of human sarcoma xenotransplants by a combination of mcl-1 antisense oligonucleotides with low-dose cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Regulation of MCL1 through a serum response factor/Elk-1-mediated mechanism links expression of a viability-promoting member of the BCL2 family to the induction of hematopoietic cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

A randomized phase II study of two schedules of bryostatin-1 (NSC339555) in patients with advanced malignant melanoma: A National Cancer Institute of Canada Clinical Trials Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

CTL granules: evolution of vesicles essential for combating virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Granzyme B: pro-apoptotic, antiviral and antitumor functions

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Management of cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

IAPs, RINGs and ubiquitylation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Small interfering RNA targeting bcl-2 sensitizes malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Loss of protein kinase C function induces an apoptotic response

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Life in the balance: how BH3-only proteins induce apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Structural basis of IAP recognition by Smac/DIABLO

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Addicted to death: invasive cancer and the immune response to unscheduled cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Role of BAX in the apoptotic response to anticancer agents

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Translational control of tumor necrosis factor-related apoptosis-inducing ligand death receptor expression in melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Death by design: the big debut of small molecules.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Caspase-2 function in response to DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Activation of the extracellular signal regulated kinase (ERK) pathway in human melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

Alkylating DNA damage stimulates a regulated form of necrotic cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2806%2951004-6

7 January 2021

10.1016/S0074-7696(06)51004-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16939779%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference